- Home
- IMVT vs CHDN Comparison
IMVT vs CHDN Comparison
Compare IMVT & CHDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMVT | CHDN |
|---|---|---|
| Founded | 2018 | 1928 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3B | 6.0B |
| IPO Year | 2019 | 1995 |
Fundamental Metrics
Financial Performance| Metric | IMVT | CHDN |
|---|---|---|
| Price | $37.88 | $88.33 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 9 |
| Target Price | $33.00 | ★ $138.44 |
| AVG Volume (30 Days) | ★ 1.5M | 903.9K |
| Earning Date | 05-28-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 0.43% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 5.49 |
| Revenue | N/A | ★ $1,809,800,000.00 |
| Revenue This Year | N/A | $5.75 |
| Revenue Next Year | N/A | $3.52 |
| P/E Ratio | ★ N/A | $15.30 |
| Revenue Growth | N/A | ★ 13.31 |
| 52 Week Low | $14.32 | $81.45 |
| 52 Week High | $39.28 | $118.46 |
Technical Indicators
Market Signals| Indicator | IMVT | CHDN |
|---|---|---|
| Relative Strength Index (RSI) | 69.37 | 52.02 |
| Support Level | $25.13 | $87.85 |
| Resistance Level | N/A | $89.62 |
| Average True Range (ATR) | 1.44 | 3.12 |
| MACD | 0.42 | -0.09 |
| Stochastic Oscillator | 85.29 | 48.31 |
Price Performance
Historical ComparisonAbout IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.
About CHDN Churchill Downs Incorporated
Churchill Downs Inc is a gaming entertainment, online wagering, and racing company. It operates through three business segments: Live and Historical Racing, Wagering Services, and Gaming. The Live and Historical Racing segment includes live and historical pari-mutuel racing. The Wagering Services segment includes the revenue and expenses from pari-mutuel wagers through TwinSpires, companies retail and online sports betting business and Gaming segment includes revenue and expenses for the casino properties and associated racetracks that support the casino license. The Gaming segment generates revenue and expenses from slot machines, video lottery terminals, video poker, HRMs, ancillary food and beverage services, hotel services, commission on pari-mutuel wagering, and racing events.